Product Datasheet  
EPHA3/4/5 (Phospho-Tyr779/833) Antibody  
Catalog Number: 11729  
Technical:tech@swbio.com  
Information:info@swbio.com  
Description  
  • host_species:  
  • Rabbit
  • Amount:  
  • 100μgμg
  • Swiss-Prot No.:  
  • Swiss-Prot#: P29320/54764/54756;
    NCBI Gene#: 2042/2043;
    NCBI Protein#: NP_004429.1.
  • Form of Antibody:  
  • Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
  • Storage:  
  • Store at -20˚C/1 year
  • Immunogen:  
  • Peptide sequence around phosphorylation site of tyrosine 779/833 (E-A-Y(p)-T-T)/(A-A-Y(p)-T-T) derived from Human EPHA3/4/5.
  • reactivity:  
  • Hu
  • appl_detail:  
  • Immunohistochemistry: 1:50~1:100

  • other_names:  
  • EPA3; ETK; HEK; MEK4; REK
  • Purification:  
  • Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
  • Specificity:  
  • The antibody detects endogenous levels of EPHA3/4/5 only when phosphorylated at tyrosine 779/833.
  • Applications:  
  • IHC
  • Background:  
  • This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands.

    Wicks I.P., Proc. Natl. Acad. Sci. U.S.A. 89:1611-1615(1992).
    Chiari R., Cancer Res. 60:4855-4863(2000).
    Boyd A.W., J. Biol. Chem. 267:3262-3267(1992).




 
© Signalway Biotechnology All Rights Reserved.